Sort
85,873 grants matching “alzheimers”
Alzheimer's Disease Research Center
$2,212,107Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2019 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies
$2,211,865David A Bennett · Rush University Medical Center · R01 · FY2021 · AG
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,211,352Redford B Williams · Duke University · P01 · FY2012 · HL
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementia
$2,211,239Brian J Popko · Northwestern University At Chicago · RF1 · FY2021 · AG
Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia
$2,211,067Emily J Rogalski · University Of Chicago · R01 · FY2025 · AG
Neurocognitive Disorder after Appendectomy in the Elderly: A Natural Experiment
$2,210,194Jeffrey H Silber · Children'S Hosp Of Philadelphia · RF1 · FY2017 · AG
In Vivo Control and Functional Visualization of Stem Cell-Driven CNS Regeneration
$2,209,908Jin Hyung Lee · Stanford University · DP2 · FY2010 · OD
Brain Digital Slide Archive: An Open Source Platform for data sharing and analysis of digital neuropathology
$2,209,466David Andrew Gutman · Emory University · U24 · FY2023 · NS
AI-Enhanced and Culturally Adapted STAR-C for Latino Caregivers: A Stage I Pilot Study
$2,208,923Magaly Ramirez · University Of Washington · RF1 · FY2025 · AG
Generation and characterization of a mouse model exhibiting beta-amyloidosis and tauopathy with nuclear depletion of TDP-43
$2,208,827Philip C Wong · Johns Hopkins University · R61 · FY2019 · NS
Administrative Component
$2,208,805Michael A Province · Washington University · U19 · FY2022 · AG
Alzheimer's Disease Research Center
$2,208,597Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2018 · AG
Mechanisms of inherited neurodegenerative diseases
$2,208,322Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
$2,208,081Meredith Hay · University Of Arizona · U01 · FY2023 · AG
Exceptional Longevity Data Management and Coordinating Center
$2,207,794Anna K Greenwood · Sage Bionetworks · U24 · FY2022 · AG
Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease
$2,207,391Wayne W Poon · University Of California-Irvine · RF1 · FY2021 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial
$2,207,066Eric M Reiman · Banner Health · R01 · FY2018 · AG
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD cohort
$2,206,720Marilyn S Albert · Johns Hopkins University · U01 · FY2012 · AG
Alzheimer's Disease Cooperative Study
$2,206,643Howard Feldman · University Of California, San Diego · U19 · FY2017 · AG
Aging in the Brain: Role of the Fibrous Proteins
$2,206,350Dennis J Selkoe · Brigham And Women'S Hospital · RF1 · FY2017 · AG
A comprehensive study of tandem repeat variation as a cause of Alzheimer's disease
$2,206,266Andrew James Sharp · Icahn School Of Medicine At Mount Sinai · RF1 · FY2023 · AG
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
$2,206,194Jeffery W Kelly · Scripps Research Institute, The · P01 · FY2010 · AG
DATA CORE (DC)
$2,206,124Ronald G. Thomas · University Of California, San Diego · U01 · FY2007 · AG
Finance, Cognition, and Default Network in Aging (FCDNA)
$2,204,479Duke Han · University Of Southern California · RF1 · FY2021 · AG
Neuroimaging Analysis Center (NAC)
$2,204,015Ron Kikinis · Brigham And Women'S Hospital · P41 · FY2015 · EB